Prevalence of silent myocardial ischaemia in new-onset middle-aged Type 2 diabetic patients without other cardiovascular risk factors

Diabetic Medicine

Volumn 23, Issue 7, 2006, Pages 775-779

  Fornengo, P ^a   Bosio, A ^a   Epifani, G ^a   Pallisco, O ^a   Mancuso, A ^a   Pascale, C ^a  

^a Faculty of Medicine and Surgery School of Nursing   (Italy)

Author keywords

Silent myocardial ischaemia; Type 2 diabetes

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; RISK ASSESSMENT; RISK REDUCTION; SCREENING;

AGE OF ONSET; AGED; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREVALENCE;

EID: 33748552350     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2006.01910.x     Document Type: Article

References (43)

1. Pearson TA, Blair SN, Daniels SR. American Heart Association guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular disease. American Heart Association Science Advisory and Coordinating Committee. Circulation 2002; 106: 388-391.
2. Lüscher TF, Creager MA. Diabetes and vascular disease pathophysiology, clinical consequences, and medical therapy: part II. Circulation 2003; 108: 1655-1661.
3. Fava S, Azzopardi J, Muscat HA, Fenech FF. Factors that influence outcome in diabetic subjects with myocardial infarction. Diabetes Care 1993; 16: 1615-1618.
4. American Diabetes Association. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care 1998; 21: 1551-1559.
5. Gibbons RJ, Balady GJ, Beasley JW, Bricker JT, Duvernoy WF, Froelicher VF et al. ACC/AHA guidelines for exercise testing. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on exercise testing). J Am Coll Cardiol 1997; 30: 260-311.
6. Fazzini PE, Prati PL, Rovelli F, Antoniucci D, Menghini F, Seccareccia F et al. Epidemiology of silent myocardial ischemia in asymptomatic middle-aged men (the ECCIS project). Am J Cardiol 1993; 72: 1383-1388.
7. Weiner DA, Ryan TJ, Parson L, Fisher LD, Chaitman BR, Sheffield LT et al. Significance of silent myocardial ischemia during exercise testing in patients with diabetes mellitus: a report from the Coronary Artery Surgery Study (CASS) registry. Am J Cardiol 1991; 68: 729-734.
8. Koistinen MJ. Prevalence of asymptomatic myocardial ischemia in diabetic subjects. Br Med J 1990; 301: 92-95.
9. Naka M, Hiramtsu K, Aizawa T, Momose A, Yoshizawa K, Shigematsu S et al. Silent myocardial ischemia in patients with non-insulin dependent diabetes mellitus as judged by treadmill exercise testing and coronary angiography. Am Heart J 1992; 123: 46-53.
10. Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassmann-Vague V. Silent myocardial in patients with diabetes. Who to screen? Diabetes Care 1999; 22: 1396-1400.
11. Bacci S, Villella M, Villella A, Langialonga T, Grilli M, Rauseo A et al. Screening for silent myocardial ischemia in type 2 diabetic patients with additional atherogenic risk factors: applicability and accuracy of the exercise stress test. Eur J Endocrinol 2002; 147: 649-654.
12. Diamond GA, Forrester JS, Hirsh M, Staniloff HM, Vas R, Berman DS, Swan HJ. Application of conditional probability analysis to the clinical diagnosis of coronary artery disease. J Clin Invest 1980; 65: 1210-1221.
13. Cohn PF. Prognosis in exercise-induced silent myocardial ischemia and implications for screening asymptomatic populations. Prog Cardiovasc Dis 1992; 34: 399-412.
14. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed pre-diabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? J Am Med Assoc 1990; 263: 2893-2898.
15. Milan Study on Atherosclerosis and Diabetes (MiSAD) Group. Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in non insulin-dependent diabetes mellitus. Am J Cardiol 1997; 79: 134-139.
16. American Diabetes Association, Members of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2002; 25: S5-S20.
17. Monge L, Bruno G, Pinach S, Grassi G, Maghenzani G, Dani F, Pagano G. A clinically orientated approach increases the efficiency of screening for latent autoimmune diabetes in adults (LADA) in a large clinic-based cohort of patients with diabetes onset over 50 years. Diabet Med 2004; 21: 456-459.
18. Gibbons RJ, Brady GS, Bricker JT. ACC/AHA 2002 guideline update for exercise testing: summary article. a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2002; 106: 1883-1892.
19. Stammer J, Vaquero O, Nekton JD, Wentwoth D. Diabetes, other risk factors, and 12-years cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-444.
20. Uusitupa MI, Niskanen LK, Siitonen O, Voutilanen E, Pyorala K. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 diabetic and non-diabetic subjects. Diabetologia 1993; 36: 1175-1184.
21. De Stafano F, Ford ES, Newman J, Stevenson JM, Wetterhall SF, Anda RF et al. Risk factors for coronary heart disease mortality among persons with diabetes. Ann Epidemiol 1993; 3: 27-34.
22. Puel J, Valensi P, Vanzetto G, Lassmann-Vague V, Monin JL, Molin P et al. Identification of myocardial ischemia in the diabetic patient. Joint ALFEDIAM and SFC recommendations. Diabetes Metab 2004; 30: 3S3-3S18.
23. Langer A, Freeman MR, Josse RG, Steiner G, Armstrong PW. Detection of silent myocardial ischemia in diabetes mellitus. Am J Cardiol 1991; 67: 1073-1078.
24. Scheidt-Nave C, Barrett-Connor E, Wingard DL. Resting electrocardiographic abnormalities suggestive of asymptomatic ischemic heart disease associated with non insulin dependent diabetes mellitus in a defined population. Circulation 1990; 81: 899-906.
25. Rewers M, Shetterly SM, Baxter J, Marshall JA, Hamman RF. Prevalence of coronary heart disease in subjects with normal and impaired glucose tolerance and non-insulin dependent diabetes mellitus in a biethnic Colorado population. The San Luis Valley Diabetes Study. Am J Epidemiol 1992; 135: 1321-1327.
26. Rutter MK, McComb JM, Brady S, Marshall SM. Silent myocardial ischemia and microalbuminuria in asymptomatica subjects with non-insulin-dependent diabetes mellitus. Am J Cardiol 1999; 83: 27-31.
27. Redberg RF, Greenland P, Fuster V, Pyorala K, Blair SN, Folsmo AR et al. Prevention conference VI: diabetes and cardiovascular disease. Writing group III: assessment in person with diabetes. Circulation 2002; 105: e144-152.
28. Preventive US Services Task Force. Screening for coronary heart disease: recommendation statement. Ann Intern Med 2004; 140: 569-572.
29. Fowler-Brown A, Pignone M, Pletcher M, Tice JA, Sutton SF, Lohr KN. Exercise tolerance testing to screen for coronary heart disease: a systematic review for the technical support for the US Preventive Services Task Force Ann Intern Med 2004; 140: W9-24.
30. Paillole C, Ruiz J, Juliard JM, Leblanc H, Gourgon R, Passa P. Detection of coronary artery disease in diabetic patients. Diabetologia 1995; 38: 726-31.
31. Rubler S, Gerber D, Reitano J, Chokshi V, Fisher VJ. Predictive value of clinical and exercise variable for detection of coronary artery disease in men with diabetes mellitus. Am J Cardiol 1987; 59: 1310-3.
32. Nesto RW, Watson FS, Kovalchuck GJ, Zarich SW, Hill T, Lewis SM et al. Silent myocardial ischemia and infarction in diabetics with peripheral vascular disease: assessment by dypiridamole thallium-201 scintigraphy. Am Heart J 1990; 120: 1073-1077.
33. Kumar R, Patel CD, Marwah A, Gupta R, Sharma S, Malhotra A. Detection of coronary artery disease by stress thallium scintigraphy in diabetic patients. Nucl Med Commun 2001; 22: 287-289.
34. Cosson E, Paycha F, Paries J, Cattan S, Ramadan A, Meddah D et al. Detecting silent coronary stenoses and stratifying cardiac risk in patients with diabetes: ECG stress test or exercise myocardial scintigraphy? Diabet Med 2004; 21: 342-348.
35. Hu FB, Stampfer MJ, Haffner SM, Solomon CG, Willet WC, Manson JE. Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care 2002; 25: 1129-1134.
36. Adler AI, Neil AW, Manely SE, Holman RR, Turner RC. UKPDS 47 - Hyperglycaemia and hyperinsulinaemia at diagnosis of diabetes and their association to subsequent cardiovascular disease in the UK Prospective Diabetes Study. Am Heart J 1999; 138: S353-S359.
37. May O, Arildsen H, Damsgaard EM, Mickley H. Prevalence and prediction of silent ischaemia in diabetes mellitus: a population-based study. Cardiovasc Res 1997; 34: 241-247.
38. Stern MP. Diabetes and cardiovascular disease: the 'common soil' hypothesis. Diabetes 1995; 44: 369-374.
39. Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC, Lenfant C, for the Conference Participants. Definition of metabolic syndrome: report of the National Heart, Lung and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-438.
40. BARI Investigators. Seven-year outcome in the bypass-angioplasty revascularization investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 2000; 35: 1122-1129.
41. Feit F, Brooks MM, Sopko G, Keller NM, Rosen A, Krone R et al. Long-term clinical outcome in the Bypass Angioplasty Revascularization Investigation Registry. Circulation 1999; 34: 476-485.
42. Van Belle E, Bauters C, Hubert E, Bodart JC, Abolmaali K, Meurice T et al. Restenosis rate in diabetic patients. A comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation 1997; 96: 1454-1460.
43. Nitenberg A, Valensi P, Sachs R, Cosson E, Attali JR, Antony I. Prognostic value of epicardial coronary artery constriction to the cold pressor test in type 2 diabetic patients with angiographically normal coronary arteries and no other major risk factors. Diabetes Care 2004; 27: 208-215.